Chemotherapy and radiotherapy downregulate the activity and expression of DNA methyltransferase and enhance Bcl-2/E1B-19-kDa interacting protein-3-Induced apoptosis in human colorectal cancer cells

Chemotherapy

Volumn 58, Issue 6, 2013, Pages 445-453

  Deng, Qian ^a   Huang, Chun Mei ^a   Chen, Ni ^a   Li, Li ^a   Wang, Xiao Dong ^a   Zhang, Wen ^a   Bi, Feng ^a   Tang, Qiu Lin ^a   Li, Zhi Ping ^a   Wang, Wei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

BNIP3; Chemotherapy; Colorectal cancer; DNA methyltransferase; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; DNA METHYLTRANSFERASE 1; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MESSENGER RNA; OXALIPLATIN; PROTEIN BNIP3;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS; RETROSPECTIVE STUDIES; UP-REGULATION;

EID: 84873033322     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000345916     Document Type: Article

References (30)

1. Chen YC, Hunter DJ: Molecular epidemiology of cancer. CA Cancer J Clin 2005; 55: 45-54.
2. Fulda S, Debatin KM: Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006; 25: 4798-4811.
3. Chen G, Ray R, Dubik D, et al: The E1B 19K/ Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apotosis. J Exp Med 1997; 186: 1975-1983.
4. Yasuda M, Theodorakis P, Subramanian T, et al: Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J BiolChem 1998; 273: 12415-12421.
5. Ray R, Chen G, Vande Velde C, et al: BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3(BH) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem 2000; 275: 1439-1448.
6. Yamashita S, Tsujino Y, Moriguchi K, et al: Chemical genomic screening for methylation- silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci 2006; 97: 64-71.
7. Murai M, Toyota M, Suzuki H, et al: Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer. Clin Cancer Res 2005; 11: 1021-1027.
8. Yuan RH, Jeng YM, Pan HW, et al: Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res 2007; 13: 5368-5376.
9. Zolk O, Solbach TF, Eschenhagen T, et al: Activation of negative regulators of the hypoxiainducible factor (HIF) pathway in human end-stage heart failure. Biochem Biophys Res Commun 2008; 376: 315-320.
10. Bai ZY, Xu GB, Wu SL: Detection of DNAmethyltransferase activity of leukemia cells with radiology microassay. J Bei Jing Med Univ 2000; 32: 76-78.
11. Nakazato T, Sagawa M, Yamato K, et al: Myeloperoxidase is a key regulator of oxidative stress mediated apoptosis in myeloid leukemic cells. Clin Cancer Res 2007; 13: 5436-5445.
12. Gong Y, Han XD: Nonylphenol-induced oxidative stress and cytotoxicity in testicular Sertoli cells. Reprod Toxicol 2006; 22: 623-630.
13. Sowter HM, Ratcliffe PJ, Watson P, et al: HIF- 1-dependent regulation of hypoxic induction of cell death factors BNIP3 and NIXin human tumors. Cancer Res 2001; 61: 6669-6673.
14. Sowter HM, Ferguson M, Pym C, et al: Expression of the cell death gene BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade. J Pathol 2003; 201: 573-580.
15. Fei P, Wang W, Kim SH, et al: Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. CancerCell 2004; 6: 597-609.
16. Van Loo G, Saelens X, van Gurp M, et al: The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 2002; 9: 1031-1042.
17. Vande Velde C, Cizeau J, Dubik D, et al: BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 2000; 20: 5454-5468.
18. Regula KM, Ens K, Kirshenbaum LA: Inducible expression of BNip3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res 2002; 91: 226-231.
19. Yan J, Yun H, Yang Y, et al: Upregulation of BNIP3 promotes apoptosis of lung cancer cells that were induced by p53. Biochem Biophys Res Commun 2006; 346: 501-507.
20. Balcer-Kubiczek EK, Attarpour M, Jiang J, et al: Cytotoxicity of docetaxel (Taxotere) used as a single agent and in combination with radiation in human gastric, cervicaland pancreatic cancer cells. Chemotherapy 2006; 52: 231-240.
21. Feng X, Liu X, Zhang W, et al: p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. EMBO J 2011; 30: 3397-3415.
22. Murai M, Toyota M, Satoh A, et al: Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours. Br J Cancer 2005; 92: 1165-1172.
23. Abe T, Toyota M, Suzuki H, et al: Upregulation of BNIP3 by 5-aza-2'-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death. J Gastroenterol 2005; 40: 504-510.
24. Ehrlich M Buchanan KL, Tsien F, et al: DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum Mol Genet 2001; 10: 2917-2931.
25. Wade PA: Methyl CpG-binding proteins and transcriptional repression. Bioessays 2001; 23: 1131-1137.
26. Jackson-Grusby L, Beard C, Possemato R, et al: Loss of genomic methylation causes p53- dependent apoptosis and epigenetic deregulation. Nat Genet 2001; 27: 31-39.
27. Schmidt-Kastner R, Aguirre-Chen C, Kietzmann T, et al: Nuclear localization of the hypoxia- regulated pro-apoptotic protein BNIP3 after global brain ischemia in the rat hippocampus. Brain Res 2004; 1001: 133-142.
28. Burton TR, Henson ES, Baijal P, et al: The pro-cell death Bcl-2 family member, BNIP3, is localized to the nucleus of human glial cells: implications for glioblastoma multiforme tumor cell survival under hypoxia. Int J Cancer 2006; 118: 1660-1669.
29. Giatromanolaki A, Koukourakis MI, Sower HM, et al: BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer. Clin Cancer Res 2004; 10: 5566-5571.
30. Cleven AH, Wouters BG, Schutte B, et al Poorer outcome in stromal HIF-2 alpha-and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis. Br J Cancer 2008; 99: 727-733.